"10.1371_journal.pone.0025985","plos one","2011-10-20T00:00:00Z","Xinhui Wang; Gyeong Hoon Kang; Mihaela Campan; Daniel J Weisenberger; Tiffany I Long; Wendy Cozen; Leslie Bernstein; Anna H Wu; Kimberly D Siegmund; Darryl Shibata; Peter W Laird","Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America; Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America; Department of Pathology, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Division of Population Sciences, City of Hope National Medical Center, Duarte, California, United States of America; Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America; Department of Biochemistry and Molecular Biology, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America; University of Southern California Epigenome Center and USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States of America","Conceived and designed the experiments: PWL KDS AHW DJW GHK. Performed the experiments: GHK DJW MC TIL. Analyzed the data: XW KDS AHW PWL. Contributed reagents/materials/analysis tools: AHW DS WC LB GHK. Wrote the paper: XW KDS MC PWL.","The authors have read the journal's policy and have the following conflicts: Peter W. Laird is a shareholder, consultant and scientific advisory board member of Epigenomics, AG, which has a commercial interest in DNA methylation markers. This work was not supported by Epigenomics, AG. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","10","Xinhui Wang","XW",11,TRUE,5,4,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
